View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

Hikma Pharmaceuticals to take over US generic injectables manufacturer

June 5, 2014
London-based multinational company Hikma Pharmaceuticals PLC has reached an asset acquisition agreement with Ben Venue Laboratories for the purchase of its U.S. generic injectables division, Bedford Laboratories, for $300 million.
Read More

US pharma major Abbott to pay $2.9 billion for Chile's CFR

June 3, 2014
U.S. pharmaceuticals and healthcare products major Abbott Laboratories has agreed to acquire Chile-based pharmaceutical firm CFR Pharmaceuticals SA in a deal worth $2.9 billion.
Read More

Sun Pharma's response to FDA import ban seen as 'inadequate'

May 27, 2014
According to the U.S. Food and Drug Administration, Sun Pharma has failed to take sufficient measures to correct the violations that led to the enforcement action.
Read More

EU, US health officials team up to fight antimicrobial resistance

May 19, 2014
Health officials from both sides of the Atlantic have been working together to tackle antimicrobial resistance under their joint Transatlantic Taskforce on Antimicrobial Resistance.
Read More

Sanofi looking to shed multi-billion portfolio to optimize assets

May 6, 2014
French pharmaceutical giant Sanofi SA is exploring options to sell a range of older drugs, with an estimated value of the portfolio between $7 billion and $8 billion.
Read More

Pfizer proposes $101 billion takeover to AstraZeneca, reports claim

April 28, 2014
U.S. pharmaceutical company Pfizer has expressed interest in taking over Anglo-Swedish giant AstraZeneca for a total of $101 billion.
Read More

Lupin recalls 9,000 bottles of antibiotic drug

April 21, 2014
Two lots of Suprax, an antibiotic drug used to treat bacterial infections, are being withdrawn from the U.S. market because the product does not meet federal standards for impurities.
Read More

US, EU generic drug makers call for regulatory cooperation

April 16, 2014
Generic pharmaceuticals manufacturers from Europe and the United States have urged regulators on both sides of the Atlantic to adopt a strategy of "regulatory convergence."
Read More

Scientists find benefits of Tamiflu overestimated

April 14, 2014
A new study raises concerns that the effect of the vastly popular influenza treatment drug may have been overestimated.
Read More

US demand for pharma excipients to rise 4.3% per year through 2018

April 3, 2014
Excipients in oral formulations, such as tablets and capsules, will be well positioned for strong market performance.
Read More